Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma

Thuy B. Tran, Shishir K. Maithel, Timothy M. Pawlik, Tracy S. Wang, Ioannis Hatzaras, John E. Phay, Ryan C. Fields, Sharon M. Weber, Jason K. Sicklick, Adam C. Yopp, Quan Yang Duh, Carmen C. Solorzano, Konstantinos I. Votanopoulos, George A. Poultsides

Research output: Contribution to journalArticle

Abstract

Background Adrenocortical carcinoma (ACC) is an aggressive malignancy typically resistant to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic disease, remains the only potentially curative option. However, the subset of patients who will benefit from repeat resection in this setting remains ill defined. The objective of this study was to propose a prognostic clinical score that facilitates selection of patients for repeat resection of recurrent ACC. Study Design Patients who underwent curative-intent repeat resection for recurrent ACC at 1 of 13 academic medical centers participating in the US ACC Study Group were identified. End points included morbidity, mortality, and overall survival. Results Fifty-six patients underwent repeat curative-intent resection for recurrent ACC (representing 21% of 265 patients who underwent resection for primary ACC) from 1997 to 2014. Median age was 52 years. Sites of resected recurrence included locoregional only (54%), lung only (14%), liver only (12%), combined locoregional and lung (4%), combined liver and lung (4%), and other distant sites (12%). Thirty-day morbidity and mortality rates were 40% and 5.4%, respectively. Cox regression analysis revealed that the presence of multifocal recurrence, disease-free interval <12 months, and extrapulmonary distant metastases were independent predictors of poor survival. A clinical score consisting of 1-point each for the 3 variables demonstrated good discrimination in predicting survival after repeat resection (5-year: 72% for 0 points, 32% for 1 point, 0% for 2 or 3 points; p = 0.0006, area under the curve = 0.78). Conclusions Long-term survival after repeat resection for recurrent ACC is feasible when 2 of the following factors are present: solitary tumor, disease-free interval >12 months, and locoregional or pulmonary recurrence.

Original languageEnglish (US)
Pages (from-to)794-803
Number of pages10
JournalJournal of the American College of Surgeons
Volume223
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Adrenocortical Carcinoma
Survival
Lung
Recurrence
Morbidity
Mortality
Liver
Patient Selection
Regression Analysis
Radiation
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Tran, T. B., Maithel, S. K., Pawlik, T. M., Wang, T. S., Hatzaras, I., Phay, J. E., ... Poultsides, G. A. (2016). Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. Journal of the American College of Surgeons, 223(6), 794-803. https://doi.org/10.1016/j.jamcollsurg.2016.08.568

Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. / Tran, Thuy B.; Maithel, Shishir K.; Pawlik, Timothy M.; Wang, Tracy S.; Hatzaras, Ioannis; Phay, John E.; Fields, Ryan C.; Weber, Sharon M.; Sicklick, Jason K.; Yopp, Adam C.; Duh, Quan Yang; Solorzano, Carmen C.; Votanopoulos, Konstantinos I.; Poultsides, George A.

In: Journal of the American College of Surgeons, Vol. 223, No. 6, 01.12.2016, p. 794-803.

Research output: Contribution to journalArticle

Tran, TB, Maithel, SK, Pawlik, TM, Wang, TS, Hatzaras, I, Phay, JE, Fields, RC, Weber, SM, Sicklick, JK, Yopp, AC, Duh, QY, Solorzano, CC, Votanopoulos, KI & Poultsides, GA 2016, 'Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma', Journal of the American College of Surgeons, vol. 223, no. 6, pp. 794-803. https://doi.org/10.1016/j.jamcollsurg.2016.08.568
Tran, Thuy B. ; Maithel, Shishir K. ; Pawlik, Timothy M. ; Wang, Tracy S. ; Hatzaras, Ioannis ; Phay, John E. ; Fields, Ryan C. ; Weber, Sharon M. ; Sicklick, Jason K. ; Yopp, Adam C. ; Duh, Quan Yang ; Solorzano, Carmen C. ; Votanopoulos, Konstantinos I. ; Poultsides, George A. / Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. In: Journal of the American College of Surgeons. 2016 ; Vol. 223, No. 6. pp. 794-803.
@article{934b6eebaa45476ba299dbb549bc2c9f,
title = "Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma",
abstract = "Background Adrenocortical carcinoma (ACC) is an aggressive malignancy typically resistant to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic disease, remains the only potentially curative option. However, the subset of patients who will benefit from repeat resection in this setting remains ill defined. The objective of this study was to propose a prognostic clinical score that facilitates selection of patients for repeat resection of recurrent ACC. Study Design Patients who underwent curative-intent repeat resection for recurrent ACC at 1 of 13 academic medical centers participating in the US ACC Study Group were identified. End points included morbidity, mortality, and overall survival. Results Fifty-six patients underwent repeat curative-intent resection for recurrent ACC (representing 21{\%} of 265 patients who underwent resection for primary ACC) from 1997 to 2014. Median age was 52 years. Sites of resected recurrence included locoregional only (54{\%}), lung only (14{\%}), liver only (12{\%}), combined locoregional and lung (4{\%}), combined liver and lung (4{\%}), and other distant sites (12{\%}). Thirty-day morbidity and mortality rates were 40{\%} and 5.4{\%}, respectively. Cox regression analysis revealed that the presence of multifocal recurrence, disease-free interval <12 months, and extrapulmonary distant metastases were independent predictors of poor survival. A clinical score consisting of 1-point each for the 3 variables demonstrated good discrimination in predicting survival after repeat resection (5-year: 72{\%} for 0 points, 32{\%} for 1 point, 0{\%} for 2 or 3 points; p = 0.0006, area under the curve = 0.78). Conclusions Long-term survival after repeat resection for recurrent ACC is feasible when 2 of the following factors are present: solitary tumor, disease-free interval >12 months, and locoregional or pulmonary recurrence.",
author = "Tran, {Thuy B.} and Maithel, {Shishir K.} and Pawlik, {Timothy M.} and Wang, {Tracy S.} and Ioannis Hatzaras and Phay, {John E.} and Fields, {Ryan C.} and Weber, {Sharon M.} and Sicklick, {Jason K.} and Yopp, {Adam C.} and Duh, {Quan Yang} and Solorzano, {Carmen C.} and Votanopoulos, {Konstantinos I.} and Poultsides, {George A.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.jamcollsurg.2016.08.568",
language = "English (US)",
volume = "223",
pages = "794--803",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma

AU - Tran, Thuy B.

AU - Maithel, Shishir K.

AU - Pawlik, Timothy M.

AU - Wang, Tracy S.

AU - Hatzaras, Ioannis

AU - Phay, John E.

AU - Fields, Ryan C.

AU - Weber, Sharon M.

AU - Sicklick, Jason K.

AU - Yopp, Adam C.

AU - Duh, Quan Yang

AU - Solorzano, Carmen C.

AU - Votanopoulos, Konstantinos I.

AU - Poultsides, George A.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background Adrenocortical carcinoma (ACC) is an aggressive malignancy typically resistant to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic disease, remains the only potentially curative option. However, the subset of patients who will benefit from repeat resection in this setting remains ill defined. The objective of this study was to propose a prognostic clinical score that facilitates selection of patients for repeat resection of recurrent ACC. Study Design Patients who underwent curative-intent repeat resection for recurrent ACC at 1 of 13 academic medical centers participating in the US ACC Study Group were identified. End points included morbidity, mortality, and overall survival. Results Fifty-six patients underwent repeat curative-intent resection for recurrent ACC (representing 21% of 265 patients who underwent resection for primary ACC) from 1997 to 2014. Median age was 52 years. Sites of resected recurrence included locoregional only (54%), lung only (14%), liver only (12%), combined locoregional and lung (4%), combined liver and lung (4%), and other distant sites (12%). Thirty-day morbidity and mortality rates were 40% and 5.4%, respectively. Cox regression analysis revealed that the presence of multifocal recurrence, disease-free interval <12 months, and extrapulmonary distant metastases were independent predictors of poor survival. A clinical score consisting of 1-point each for the 3 variables demonstrated good discrimination in predicting survival after repeat resection (5-year: 72% for 0 points, 32% for 1 point, 0% for 2 or 3 points; p = 0.0006, area under the curve = 0.78). Conclusions Long-term survival after repeat resection for recurrent ACC is feasible when 2 of the following factors are present: solitary tumor, disease-free interval >12 months, and locoregional or pulmonary recurrence.

AB - Background Adrenocortical carcinoma (ACC) is an aggressive malignancy typically resistant to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic disease, remains the only potentially curative option. However, the subset of patients who will benefit from repeat resection in this setting remains ill defined. The objective of this study was to propose a prognostic clinical score that facilitates selection of patients for repeat resection of recurrent ACC. Study Design Patients who underwent curative-intent repeat resection for recurrent ACC at 1 of 13 academic medical centers participating in the US ACC Study Group were identified. End points included morbidity, mortality, and overall survival. Results Fifty-six patients underwent repeat curative-intent resection for recurrent ACC (representing 21% of 265 patients who underwent resection for primary ACC) from 1997 to 2014. Median age was 52 years. Sites of resected recurrence included locoregional only (54%), lung only (14%), liver only (12%), combined locoregional and lung (4%), combined liver and lung (4%), and other distant sites (12%). Thirty-day morbidity and mortality rates were 40% and 5.4%, respectively. Cox regression analysis revealed that the presence of multifocal recurrence, disease-free interval <12 months, and extrapulmonary distant metastases were independent predictors of poor survival. A clinical score consisting of 1-point each for the 3 variables demonstrated good discrimination in predicting survival after repeat resection (5-year: 72% for 0 points, 32% for 1 point, 0% for 2 or 3 points; p = 0.0006, area under the curve = 0.78). Conclusions Long-term survival after repeat resection for recurrent ACC is feasible when 2 of the following factors are present: solitary tumor, disease-free interval >12 months, and locoregional or pulmonary recurrence.

UR - http://www.scopus.com/inward/record.url?scp=84996773700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996773700&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2016.08.568

DO - 10.1016/j.jamcollsurg.2016.08.568

M3 - Article

VL - 223

SP - 794

EP - 803

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -